Veronica Backlund
About Veronica Backlund
Veronica Backlund is a Senior Manager at Geron Corporation, where she has worked since 2021. She has extensive experience in regulatory affairs and clinical trial transparency, having held positions at UCB, AstraZeneca, GlaxoSmithKline, and other organizations.
Current Role at Geron Corporation
Veronica Backlund serves as a Senior Manager at Geron Corporation, a position she has held since 2021. She is based in Foster City, California. In her current role, she is involved in managing regulatory affairs and ensuring compliance with industry standards. Her experience in regulatory science contributes to the company's objectives in the biotechnology sector.
Previous Experience in Regulatory Affairs
Before joining Geron Corporation, Veronica Backlund worked at UCB as a Regulatory Scientist in Neurology from 2017 to 2021. During her four years in this role, she focused on regulatory submissions and compliance within the neurology therapeutic area. Prior to UCB, she held the position of Regulatory Affairs Manager at AstraZeneca from 2015 to 2017, where she managed regulatory strategies and submissions.
Background in Clinical Trials and Regulatory Submissions
Veronica Backlund has a solid background in clinical trials and regulatory submissions. She worked at GlaxoSmithKline Pharma GmbH as a Clinical Trial Transparency Analyst from 2013 to 2015. Additionally, she was a Regulatory Submissions Associate at Rho from 2011 to 2012 and a Regulatory Records Specialist II at INC Research from 2012 to 2013, both roles contributing to her expertise in regulatory processes.
Educational Qualifications
Veronica Backlund holds an Associate of Arts (A.A.) degree in Psychology from Central Carolina Community College, which she completed from 2003 to 2006. She furthered her education at the University of North Carolina Wilmington, where she earned a Bachelor of Science (B.S.) degree in Chemistry from 2006 to 2010. Her educational background supports her career in regulatory affairs and clinical research.